Idiopathic Macular Telangiectasia Type 1 with Ruptured Retinal Arterial Macroaneurysm Post Intravitreal Bevacizumab

Middle East Afr J Ophthalmol. 2015 Jul-Sep;22(3):396-8. doi: 10.4103/0974-9233.159779.

Abstract

A 50-year-old Indian male presented with defective vision in the right eye for 6 months. He was diagnosed to have idiopathic macular telangiectasia (IMT) type 1 associated with diffuse macular edema and multiple retinal arterial macroaneurysms (RAM). Intravitreal bevacizumab was administered for the treatment of macular edema, following which there was a rupture of a preexisting RAM with multilevel retinal hemorrhages. The hemorrhage gradually resolved over time with foveal thinning noted at last visit. We report this case for the rare occurrence of IMT type 1 and also the possibly associated rupture of RAM post intravitreal bevacizumab injection.

Keywords: Bevacizumab; Ruptured Retinal Arterial Macroaneurysms; Type 1 Idiopathic Macular Telangiectasia.

Publication types

  • Case Reports

MeSH terms

  • Aneurysm, Ruptured / diagnosis
  • Aneurysm, Ruptured / etiology*
  • Angiogenesis Inhibitors / therapeutic use*
  • Antibodies, Monoclonal, Humanized / therapeutic use*
  • Bevacizumab
  • Blindness / etiology
  • Fluorescein Angiography
  • Humans
  • Intravitreal Injections
  • Macular Edema / drug therapy*
  • Macular Edema / etiology
  • Male
  • Middle Aged
  • Postoperative Complications*
  • Retinal Artery / pathology*
  • Retinal Hemorrhage / diagnosis
  • Retinal Hemorrhage / etiology
  • Retinal Telangiectasis / diagnosis
  • Retinal Telangiectasis / etiology*
  • Tomography, Optical Coherence
  • Vascular Endothelial Growth Factor A / antagonists & inhibitors
  • Visual Acuity / physiology

Substances

  • Angiogenesis Inhibitors
  • Antibodies, Monoclonal, Humanized
  • VEGFA protein, human
  • Vascular Endothelial Growth Factor A
  • Bevacizumab